EC Number |
Inhibitors |
Structure |
---|
2.7.11.1 | (5-oxo-5,6-dihydroindolo[1,2-a]quinazolin-7-yl)acetic acid |
i.e. IQA |
|
2.7.11.1 | (5Z)-5-(1H-pyrrolo[2,3-b]pyridin-3-ylmethylidene)-2-thioxoimidazolidin-4-one |
- |
|
2.7.11.1 | (S)-2-(2-aminopyrimidiny-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridinione |
- |
|
2.7.11.1 | (Z)-5-(4-propoxybenzylidene) thiazolidine-2,4-dione |
a Pim-2 inhibitor |
|
2.7.11.1 | 1,1'-[(5-chloropyrimidine-2,4-diyl)bis[azanediyl(3-methoxy-4,1-phenylene)piperazine-4,1-diyl]]di(ethan-1-one) |
- |
|
2.7.11.1 | 1-(5-chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine |
i.e. ML-9, 0.5-1.0 mM, 50% inhibition |
|
2.7.11.1 | 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine |
i.e. H-7 |
|
2.7.11.1 | 1-(6-[[4-(2,3-dihydro-1H-indol-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]amino]-5-methoxy-2,3-dihydro-1H-indol-1-yl)-2-(dimethylamino)ethan-1-one |
- |
|
2.7.11.1 | 1-(beta-D-2'-deoxyribofuranosyl)-4,5,6,7-tetrabromo-1H-benzimidazole |
TDB, a cell-permeable selective inhibitor of CK2, inhibits the phosphorylation of OTUB1 at Ser16. In addition to CK2, TDB inhibits 3 other kinases, namely PIM1, CLK2 and DYRK1A, but none of these kinases phosphorylates OTUB1 in vitro |
|
2.7.11.1 | 1-oleoyl-2-acetylglycerol |
inhibits phorbol ester binding |
|